Gemphire Therapeutics Inc. Bonus & Incentive Agreements
11 Contracts & Agreements
- First Amendment to the NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of June 7, 2024 (Filed With SEC on June 7, 2024)
- NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan Forms of Option Grant Agreements (Filed With SEC on December 22, 2022)
- NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of December 22, 2022 (Filed With SEC on December 22, 2022)
- Form of Stock Unit Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- Form of Non-Qualified Stock Option Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- Form of Restricted Stock Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- Form of Incentive Stock Option Agreement for 2019 Equity Incentive Plan (Filed With SEC on March 30, 2020)
- 2019 Equity Incentive Plan (Filed With SEC on December 31, 2019)
- Form of Notice of Grant of Restricted Stock Bonus for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan (Filed With SEC on September 3, 2019)
- AMENDMENT TO THE GEMPHIRE THERAPEUTICS INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: April 9, 2018 APPROVED BY THE STOCKHOLDERS: May 22,... (Filed With SEC on May 24, 2018)
- GEMPHIRE THERAPEUTICS INC. 2015 EQUITY INCENTIVE PLAN APPROVED BY THE BOARD OF DIRECTORS: April 28, 2015 APPROVED BY THE STOCKHOLDERS: April 28, 2015 (Filed With SEC on April 18, 2016)
